Strides Pharma Science

BSE: 532531 | NSE: STAR | ISIN: INE939A01011 | SECTOR: Biotechnology & Drugs

881.60

-1.85 (-0.21%)
06 May 2024, 03:48 PM IST

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

5887.22887.57
10863.35864.03
20845.97846.48
50814.85815.35
100730.14730.43
300601.93602.13

News

Company Description

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche and pharmaceutical products. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Company Officers